January 3, 2013
Director Baz Luhrmann already tipped his hand in the trailer for his upcoming adaptation of "The Great Gatbsy. " Among the songs heard was the Jay-Z-led track "No Church in the Wild," his 2011 collaboration with Kanye West. The use married an examination of the empty, ostentatious wealth of the '20s with an examination of the empty, ostentatious wealth of today. This week, it came to light that "The Great Gatsby" could feature original Jay-Z works . The news was spread by the Bullitts, the musical designation for producer/musician Jeymes Samuel.
January 2, 2013 |
After sparking widespread comeback chatter last year with his album "The Bravest Man in the Universe," soul singer Bobby Womack has announced that he's experiencing early symptoms of Alzheimer's disease. "The doctor says, 'You have signs of Alzheimer's,' " Womack told the BBC's Gilles Peterson in an interview on the latter's Radio 6 program. "It's not bad yet, but it's gonna get worse. " Womack, 68, admitted that he's having trouble remembering things, including the name of Damon Albarn, who co-produced "The Bravest Man in the Universe" with XL Recordings chief Richard Russell.
December 13, 2012 |
YARUMAL, Colombia - The unusually high incidence of early-onset Alzheimer's disease in this isolated cattle town has thrust it to the forefront of global efforts to find a cure for the debilitating malady. Next spring, 100 residents of this region in northwestern Colombia who are known to carry a mutant gene linked to the disease will begin taking a therapeutic drug produced by the U.S. biotechnology firm Genentech. The five-year clinical trial, called the Alzheimer's Prevention Initiative, will cost $100 million.
November 27, 2012 |
A biological medication already widely used to treat plaque psoriasis may be able to slow the accumulation of amyloid plaques in the brain that are the hallmark of Alzheimer's disease, a new study has found. The same study found that in older mice with established Alzheimer's, this treatment approach, which suppresses the brain's immune reaction to beta amyloid, brought a marked improvement in cognitive function and may even halt or reverse early signs of Alzheimer's. The new study was published this week in the journal Nature Medicine.
September 5, 2012 |
As the National Football League kicks off a new season, a study appearing in a leading medical journal underscores the long-term costs of the game on those who play it. A study tracking 3,439 retired players with five or more seasons in the NFL found these athletes four times as likely as other men their age to die of Alzheimer's disease or amyotrophic lateral sclerosis, better known as Lou Gehrig's disease. Among the league's "speed players" - those who build up substantial speed before they make a tackle or are brought down by one - the odds of dying of those causes were even greater.
August 9, 2012 |
This post has been corrected. See note at the bottom for details. Amid the generally discouraging news about drugs that can slow or reverse the progress of Alzheimer's disease, a new study is a faint glimmer of hope: In mice whose brains are clogged with the protein deposits that characterize Alzheimer's, a drug called bexarotene substantially reversed key signs of dementia and reduced by half the telltale protein deposits of the disease....
July 11, 2012 |
Researchers have found the first gene mutation that protects against Alzheimer's disease, a finding that supports a now-controversial theory about the cause of the disease and that could eventually lead to the development of new drugs to treat the disorder. The gene mutation also protects against normal dementia of aging, suggesting that the two diseases have mechanisms in common. Alzheimer's affects an estimated 5.4 million Americans, and the prevalence increases with age: 13% of those older than 65 and 45% of those over the age of 85 have it. The disease is characterized by the buildup in the brain of particles called amyloid plaque, which are composed of a protein called amyloid beta.
CALIFORNIA | LOCAL
July 1, 2012 |
"Hello Mr. Lopez, I would very much like to meet with you. I think you will find that I have some pertinent things to say. " The email was from Dr. Arthur Rivin, 89, professor emeritus of medicine at UCLA. Rivin said he had been diagnosed in September 2009 with Alzheimer's disease, but then, something rare and amazing had happened. Using a program of therapy he developed himself, he claimed, he was now greatly improved. If I took the time to meet with him and hear all about it, Rivin suggested, together "we will do something big!"
June 29, 2012 |
This post has been corrected. See note at the bottom for details. Who hasn't heard of mad cow disease? Maybe there are a lot more diseases like that than we recognize -- such as Parkinson's, Alzheimer's and Huntington's -- that are caused by a rogue, mis-folded piece of protein that seeds other bits of protein to mis-fold as well. So argues Stanley Prusiner, a UC San Francisco professor, in a commentary in the journal Science. Prusiner won a Nobel Prize for finding that a class of neurodegenerative diseases (of which mad cow is one)
May 15, 2012 |
Asserting "we are at an exceptional moment" in the hunt for an Alzheimer'sdiseasetreatment, National Institutes of Health director Dr. Francis Collins on Tuesday promised a raft of new research aimed at stopping and reversing the memory-robbing disorder by the year 2025. In unveiling a first-ever "national strategy" on Alzheimer's disease, Collins launched several new projects and clinical trials--including a whole-genome sequencing effort to identify genes that confer vulnerability to--or protection against-- Alzheimer's, and a trial to explore whether an inhaled form of insulin will slow progression of the disease.